Spero Therapeutics
SPRO
#9395
Rank
โ‚ฌ49.86 M
Marketcap
0,91ย โ‚ฌ
Share price
-4.30%
Change (1 day)
-25.31%
Change (1 year)

Spero Therapeutics (SPRO) - Cash on Hand

Cash on Hand as of September 2024 : โ‚ฌ73.05 Million

According to Spero Therapeutics's latest financial reports the company has โ‚ฌ73.05 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Spero Therapeutics - Cash on Hand chart (from 2016 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚ฌ69.05 M-32.11%
2022-12-31โ‚ฌ0.10 B-21.32%
2021-12-31โ‚ฌ0.12 B25.29%
2020-12-31โ‚ฌ0.10 B40.88%
2019-12-31โ‚ฌ73.23 M-27.42%
2018-12-31โ‚ฌ0.10 B38.71%
2017-12-31โ‚ฌ72.74 M641.84%
2016-12-31โ‚ฌ9.8 M88.41%
2015-12-31โ‚ฌ5.2 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚ฌ46.59 M-36.21%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ13.12 B 17,860.41%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.70 B 2,239.76%๐Ÿ‡จ๐Ÿ‡ฆ Canada